Quantcast

Latest BRAF Stories

2012-11-29 14:19:28

Researchers report that screening for KRAS and BRAF mutations can reduce the cost of anti-EGFR treatment for metastatic colorectal cancer but with a very small reduction in overall survival according to a new study published on November 28 in the Journal of the National Cancer Institute. Metastatic colorectal cancer patients whose tumors harbor mutations in KRAS (and to a lesser extent, in BRAF) are unlikely to respond to costly anti-EGFR therapies. Screening of patients who are...

2012-10-25 04:01:03

GlaxoSmithKline is experimenting with a new combination of cancer medications; Petra Rietschel, MD encourages such exploration. White Plains, New York (PRWEB) October 24, 2012 Bloomberg Businessweek reports that GlaxoSmithKline Plc has combined two medications designed to treat melanoma in an effort to slow the growth of the cancer. According to the article, a study has found that this combination has succeeded in limiting the progression of the disease more successfully than a single-drug...

2012-10-01 12:24:55

Promising new data from trials aimed at delaying resistance to BRAF inhibitors Promising new data on drug combinations to treat metastatic melanoma are presented at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna. The phase I and II trials focus on combining drugs to slow the development of resistance to drugs that inhibit BRAF, a gene that is mutated in about half of melanomas. Earlier trials with drugs that target BRAF generated excitement for their...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related